Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/20047
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBlumenthal, Kimberly G-
dc.contributor.authorPeter, Jonny G-
dc.contributor.authorTrubiano, Jason-
dc.contributor.authorPhillips, Elizabeth J-
dc.date2018-12-14-
dc.date.accessioned2019-01-02T01:15:10Z-
dc.date.available2019-01-02T01:15:10Z-
dc.date.issued2018-12-14-
dc.identifier.citationLancet 2018; 393(10167): 183-198-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/20047-
dc.description.abstractAntibiotics are the commonest cause of life-threatening immune-mediated drug reactions that are considered off-target, including anaphylaxis, and organ-specific and severe cutaneous adverse reactions. However, many antibiotic reactions documented as allergies were unknown or not remembered by the patient, cutaneous reactions unrelated to drug hypersensitivity, drug-infection interactions, or drug intolerances. Although such reactions pose negligible risk to patients, they currently represent a global threat to public health. Antibiotic allergy labels result in displacement of first-line therapies for antibiotic prophylaxis and treatment. A penicillin allergy label, in particular, is associated with increased use of broad-spectrum and non-β-lactam antibiotics, which results in increased adverse events and antibiotic resistance. Most patients labelled as allergic to penicillins are not allergic when appropriately stratified for risk, tested, and re-challenged. Given the public health importance of penicillin allergy, this Review provides a global update on antibiotic allergy epidemiology, classification, mechanisms, and management.-
dc.language.isoeng-
dc.titleAntibiotic allergy.-
dc.typeJournal Article-
dc.identifier.journaltitleLancet (London, England)-
dc.identifier.affiliationDivision of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USAen
dc.identifier.affiliationInstitute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australiaen
dc.identifier.affiliationDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USAen
dc.identifier.affiliationDivision of Allergy and Clinical Immunology, Department of Medicine, University of Cape Town, Cape Town, South Africa-
dc.identifier.affiliationDepartment of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.affiliationThe National Centre for Infections in Cancer, Peter McCallum Cancer Centre, Melbourne, Victoria, Australiaen
dc.identifier.affiliationAllergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa-
dc.identifier.doi10.1016/S0140-6736(18)32218-9-
dc.identifier.orcid0000-0002-5111-6367-
dc.identifier.pubmedid30558872-
dc.type.austinJournal Article-
dc.type.austinReview-
local.name.researcherTrubiano, Jason-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptCentre for Antibiotic Allergy and Research-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

40
checked on Nov 29, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.